The Bio Report featured a podcast about precision medicine in autoimmune diseases and spoke with Alif Saleh, CEO of Scipher, to learn more about how we use gene expression data, instead of DNA, to predict response to the world’s largest selling drug class.
We are taking the data generated from our diagnostics to stratify patients based on their unique disease biology in order to rescue drugs. These drugs were shown to be safe, but failed efficacy trials due to giving the drug to everyone with the disease rather than just the sub-group with the unique disease biology the drug is supposed to treat. Our technology will allow pharmaceutical companies to find the right patient population that will benefit the most from their new drug so these patients can gain access to the drug faster than conventional methods.
